BioNews Results for DPP4:  |  |
Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?
MDLinx: Nov 6 2009 11:00AM Matching: dpp4
|
Zacks Analyst Blog Highlights: Bristol-Myers Squibb Co., AstraZeneca Plc, Merck & Co, GlaxoSmithKline and Eli
NewsBlaze: Oct 8 2009 3:51AM Matching: dpp4
|
Zacks Analyst Blog Highlights: Bristol-Myers Squibb Co., AstraZeneca Plc, Merck & Co, GlaxoSmithKline and Eli Lilly
SmartBrief: Oct 8 2009 12:04AM Matching: dpp4
|
Zacks Analyst Blog Highlights: Bristol-Myers Squibb Co., AstraZeneca Plc, Merck & Co, GlaxoSmithKline and Eli
TradingMarkets: Oct 7 2009 9:49PM Matching: dpp4
|
Zacks Analyst Blog Highlights: Bristol-Myers Squibb Co., AstraZeneca Plc, Merck & Co,
Forbes.com: Oct 7 2009 9:32PM Matching: dpp4
|
Zacks Analyst Blog Highlights: Bristol-Myers Squibb Co., AstraZeneca Plc, Merck & Co, GlaxoSmithKline and Eli
PR inside: Oct 7 2009 9:30PM Matching: dpp4
|
Zacks Analyst Blog Highlights: Bristol-Myers Squibb Co., AstraZeneca Plc, Merck & Co, GlaxoSmithKline and Eli
Yahoo! Canada: Oct 7 2009 9:29PM Matching: dpp4
|
Zacks Analyst Blog Highlights: Bristol-Myers Squibb Co., AstraZeneca Plc, Merck & Co, GlaxoSmithKline and Eli
Business Wire UK: Oct 7 2009 9:14PM Matching: dpp4
|
Zacks Analyst Blog Highlights: Bristol-Myers Squibb Co., AstraZeneca Plc, Merck & Co, GlaxoSmithKline and Eli
Business Wire: Oct 7 2009 9:08PM Matching: dpp4
|
Zacks Analyst Blog Highlights: Bristol-Myers Squibb Co., AstraZeneca Plc, Merck & Co, GlaxoSmithKline and Eli
Business Wire via Yahoo!: Oct 7 2009 9:07PM Matching: dpp4
|
Study Finds That Onglyza (saxagliptin) When Added To Metformin Was Non-Inferior To JANUVIA (SITAGLIPTIN) When
Pharma Live: Oct 5 2009 2:46PM Matching: dpp4
|
Cell Metabolism Publishes Novel TGR5-Mediated Mechanism for the Treatment of Diabetes and Obesity
PR Newswire: Sep 1 2009 9:28PM Matching: dpp4
|
